A founding member of Seeger Weiss LLP, Christopher A. Seeger is one of the nation's most versatile, respected and accomplished attorneys in cases related to drug and toxic injury.
Stephen A. Weiss co-founded Seeger Weiss in 1999 after spending a decade at a nationally prominent corporate defense firm where he represented numerous Fortune 500 companies in environmental and other commercial litigation.
David R. Buchanan focuses his practice on complex individual and class action litigation involving pharmaceutical injury, securities and investment fraud, consumer protection, and pension litigation.
Diogenes (Dion) Kekatos handles complex and class action litigation in both state and federal courts in such areas as ERISA, civil RICO, consumer fraud, environmental, antitrust, and mass tort litigation and he has immeasurable knowledge in class certification motion practice.
Moshe Horn has earned a national reputation as a trial lawyer as well as an insightful trial strategist, and is skilled in the nuances of jury research and selection in both civil and criminal matters.
Laurence Valere Nassif has tried several cases to verdict, and was a member of the Firm's trial team that achieved a $47.5 million verdict for Vioxx-related cardiovascular injury in Humeston v. Merck & Co. in 2007.
Jonathan Shub is recognized as one of the nation's leading consumer rights lawyers, based on his vast experience representing classes of individuals against well-known manufacturers of consumer products.
Michael L. Rosenberg graduated from the University of Delaware (B.A., 1986) and earned his law degree from Rutgers-Camden School of Law (J.D., 1989).
Eric H. Jaso, a former federal prosecutor and official of the U.S. Departments of Justice and Education, draws on his extensive previous experience in government and private practice in representing whistleblowers who report fraud against the government.
Sindhu S. Daniel is a partner in the firms Newark office. She is the lead attorney responsible for managing intake, pre-litigation investigation, case-specific discovery, and settlement administration for all pharmaceutical drug and medical device mass torts handled by the Firm.
No comments:
Post a Comment